Procept BioRobotics Corp’s recently made public that its EVP, CLO, CORP. SEC. Nouri Alaleh unloaded Company’s shares for reported $0.62 million on Jun 17 ’24. In the deal valued at $62.18 per share,10,000 shares were sold. As a result of this transaction, Nouri Alaleh now holds 52,472 shares worth roughly $3.09 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Shiblaq Hisham sold 26,046 shares, generating $1,777,499 in total proceeds. Upon selling the shares at $68.24, the EVP, Chief Comm. Officer now owns 55,860 shares.
Before that, Nouri Alaleh sold 30,432 shares. Procept BioRobotics Corp shares valued at $1,916,428 were divested by the EVP, CLO, CORP. SEC. at a price of $62.97 per share. As a result of the transaction, Nouri Alaleh now holds 62,472 shares, worth roughly $3.67 million.
Piper Sandler initiated its Procept BioRobotics Corp [PRCT] rating to an Overweight in a research note published on August 11, 2023; the price target was $42. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in late May with a ‘”an Outperform”‘ rating. BTIG Research began covering PRCT with “Neutral” recommendation on October 31, 2022. Truist started covering the stock on October 25, 2022. It rated PRCT as “a Buy”.
Price Performance Review of PRCT
On Tuesday, Procept BioRobotics Corp [NASDAQ:PRCT] saw its stock jump 0.22% to $58.80. Over the last five days, the stock has lost -5.22%. Procept BioRobotics Corp shares have risen nearly 40.30% since the year began. Nevertheless, the stocks have risen 76.84% over the past one year. While a 52-week high of $77.00 was reached on 05/15/24, a 52-week low of $24.83 was recorded on 01/05/24. SMA at 50 days reached $61.56, while 200 days put it at $45.73. A total of 0.6 million shares were traded, compared to the trading of 0.85 million shares in the previous session.
Levels Of Support And Resistance For PRCT Stock
The 24-hour chart illustrates a support level at 57.94, which if violated will result in even more drops to 57.07. On the upside, there is a resistance level at 59.52. A further resistance level may holdings at 60.24. The Relative Strength Index (RSI) on the 14-day chart is 34.92, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.75, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.23%. Stochastics %K at 7.30% indicates the stock is a buying.
The most recent change occurred on September 02, 2022 when Wells Fargo began covering the stock and recommended ‘”an Overweight”‘ rating along with a $49 price target.
